跳至主要内容
临床试验/NCT01485289
NCT01485289已完成不适用

Stabilimax Study Participants Collection of Additional Follow-up Data Clinical Investigation Plan R-001

Rachiotek LLC1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2011年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Rachiotek LLC
入组人数
43
试验地点
1
主要终点
Visual Analog Scale (VAS) for Leg Pain

研究概览

简要总结

The intent of this study is to complete the collection of clinical data on subjects enrolled in the Stabilimax Dynamic Spine Stabilization IDE clinical trial (#G060214) sponsored by the now defunct Applied Spine Technologies Inc . The Applied Spine assets, including the clinical trial data, were acquired by Rachiotek, LLC in 2010. When Applied Spine ceased their funding of the trial, a number of enrolled patients had not yet completed the two year follow-up visit defined as the study endpoint in the clinical investigation plan. No additional patient treatment is required to complete the study. Rachiotek has interest in pursuing IDE approval for a new study and the information collected in this study is essential for supporting the new Investigational Device Exemption application.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any patient that after having met all of the inclusion/exclusion criteria identified for the Stabilimax Investigational Device Exemption study had enrolled in the Stabilimax Investigational Device Exemption study and were implanted with the Stabilimax NZ or the control device.

排除标准

  • Any patient that has had the device removed and the adverse event follow-up report stated that the event was resolved. This applies only if the patient was formally withdrawn from the study at that time.

结局指标

主要结局

Visual Analog Scale (VAS) for Leg Pain

时间窗: Minimum 24 months post procedure

Patient demonstrates a reduction in leg pain from baseline of at least 20 mm on a 100 mm visual analog scale (VAS)

Revision, Reoperation, or Removal

时间窗: Minimum 24 months post procedure

The treated level did not require surgical revision, reoperation, removal, or supplemental fixation.

Zurich Claudication Questionnaire (ZCQ)

时间窗: Minimum 24 months post procedure

Clinically significant improvement from baseline defined by a minimum decrease of .5 as measured by the Zurich Claudication Questionnaire for both Symptom Severity(SS) and Physical Function (PF) scores

Major Device Related (MDR) Complications

时间窗: Minimum 24 months post procedure

Patient experiences no major device-related complications

次要结局

  • Presence (control) or Absence (Stabilimax)of fusion(Minimum 24 months post procedure)
  • Physician Satisfaction Scale(Immediately post procedure)
  • Oswestry Disability Index (ODI)(Minimum 24 months post procedure)
  • Adverse Events (AE)(Minimum 24 months post procedure)

研究者

发起方
Rachiotek LLC
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验